EX-32.2 6 a04-4750_1ex32d2.htm EX-32.2

Exhibit 32.2

 

Certification Pursuant To Section 1350 Of Chapter 63 Of U.S.C.

As Adopted Pursuant To Section 906 Of The Sarbanes-Oxley Act Of 2002

 

In connection with the Quarterly Report of The Immune Response Corporation (the “Company”) on Form 10-Q for the period ending March 31, 2004 as filed with the Securities and Exchange Commission, (the “Report”), which this written statement accompanies, I, Michael K. Green, Chief Financial Officer of the Company, certify pursuant to § 1350 of Chapter 63 of 18 U.S.C., as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)                                  The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)                                  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

Dated: May 12, 2004

/s/ Michael K. Green

 

 

Michael K. Green

 

Vice President, Finance and

 

Chief Financial Officer